Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Paragon 28, Inc. stock logo
FNA
Paragon 28
$13.11
+0.1%
$13.04
$4.65
$13.13
$1.10B1.471.08 million shs19.38 million shs
InMode Ltd. stock logo
INMD
InMode
$16.22
+0.6%
$17.36
$13.68
$19.85
$1.13B1.961.17 million shs932,124 shs
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
$5.25
-1.3%
$5.40
$3.75
$11.00
$303.34M2.031.74 million shs660,237 shs
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$18.06
+2.2%
$20.17
$15.75
$53.69
$1.20B1.521.50 million shs1.16 million shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Paragon 28, Inc. stock logo
FNA
Paragon 28
0.00%+0.08%+0.69%+12.68%+35.80%
InMode Ltd. stock logo
INMD
InMode
+0.56%+8.71%-10.93%-5.97%-6.57%
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
-1.32%+0.96%-6.42%-36.29%-42.24%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
+2.21%+7.12%-8.14%-50.52%-48.58%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Paragon 28, Inc. stock logo
FNA
Paragon 28
1.675 of 5 stars
1.25.00.00.02.63.30.6
InMode Ltd. stock logo
INMD
InMode
2.8239 of 5 stars
3.23.00.00.02.01.71.9
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
2.3713 of 5 stars
3.54.00.00.02.70.00.6
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
4.6667 of 5 stars
4.34.00.04.93.21.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Paragon 28, Inc. stock logo
FNA
Paragon 28
2.33
Hold$14.208.36% Upside
InMode Ltd. stock logo
INMD
InMode
2.40
Hold$21.2531.01% Upside
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
3.00
Buy$12.00128.57% Upside
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2.53
Moderate Buy$43.81142.59% Upside

Current Analyst Ratings Breakdown

Latest NNOX, FNA, TNDM, and INMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/17/2025
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$15.00 ➝ $15.00
4/14/2025
InMode Ltd. stock logo
INMD
InMode
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$16.00 ➝ $15.00
4/10/2025
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$20.00
4/9/2025
InMode Ltd. stock logo
INMD
InMode
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
4/9/2025
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
4/1/2025
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$12.00 ➝ $9.00
3/31/2025
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$15.00 ➝ $15.00
3/5/2025
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Equal Weight$45.00 ➝ $22.00
3/4/2025
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$35.00 ➝ $24.00
3/3/2025
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$42.00 ➝ $24.00
3/3/2025
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Equal Weight$38.00 ➝ $22.00
(Data available from 4/26/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Paragon 28, Inc. stock logo
FNA
Paragon 28
$256.18M4.29N/AN/A$2.05 per share6.39
InMode Ltd. stock logo
INMD
InMode
$394.82M2.86$1.56 per share10.40$10.12 per share1.60
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
$11.28M26.88N/AN/A$3.55 per share1.48
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$940.20M1.28N/AN/A$4.81 per share3.75
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Paragon 28, Inc. stock logo
FNA
Paragon 28
-$57.53M-$0.63N/AN/AN/A-25.31%-37.90%-18.22%5/14/2025 (Estimated)
InMode Ltd. stock logo
INMD
InMode
$181.27M$2.356.908.91N/A45.91%18.25%16.33%4/28/2025 (Estimated)
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
-$60.78M-$0.90N/AN/AN/A-465.38%-27.63%-24.72%5/27/2025 (Estimated)
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$222.61M-$1.46N/AN/AN/A-14.84%-44.19%-11.99%4/30/2025 (Estimated)

Latest NNOX, FNA, TNDM, and INMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/14/2025Q1 2025
Paragon 28, Inc. stock logo
FNA
Paragon 28
-$0.19N/AN/AN/A$69.62 millionN/A
4/30/2025Q1 2025
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$0.60N/AN/AN/A$220.19 millionN/A
4/28/2025Q1 2025
InMode Ltd. stock logo
INMD
InMode
$0.45N/AN/AN/A$82.21 millionN/A
3/31/2025Q4 2024
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
-$0.15-$0.23-$0.08-$0.23$3.80 million$3.00 million
3/6/2025Q4 2024
Paragon 28, Inc. stock logo
FNA
Paragon 28
-$0.12-$0.13-$0.01-$0.13$70.81 million$71.75 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Paragon 28, Inc. stock logo
FNA
Paragon 28
N/AN/AN/AN/AN/A
InMode Ltd. stock logo
INMD
InMode
N/AN/AN/AN/AN/A
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
N/AN/AN/AN/AN/A
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Paragon 28, Inc. stock logo
FNA
Paragon 28
0.79
3.50
1.60
InMode Ltd. stock logo
INMD
InMode
N/A
10.23
9.38
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
N/A
4.64
4.56
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
1.29
2.90
2.32

Institutional Ownership

CompanyInstitutional Ownership
Paragon 28, Inc. stock logo
FNA
Paragon 28
63.57%
InMode Ltd. stock logo
INMD
InMode
68.04%
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
21.49%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
N/A

Insider Ownership

CompanyInsider Ownership
Paragon 28, Inc. stock logo
FNA
Paragon 28
15.32%
InMode Ltd. stock logo
INMD
InMode
6.92%
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
7.74%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
1.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Paragon 28, Inc. stock logo
FNA
Paragon 28
343,00083.94 million70.89 millionOptionable
InMode Ltd. stock logo
INMD
InMode
48069.56 million64.75 millionOptionable
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
19057.78 million53.31 millionOptionable
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2,60066.56 million64.23 millionOptionable

Recent News About These Companies

Tandem Diabetes price target lowered to $45 from $55 at RBC Capital

New MarketBeat Followers Over Time

Media Sentiment Over Time

Paragon 28 stock logo

Paragon 28 NYSE:FNA

$13.10 +0.02 (+0.11%)
Closing price 04/17/2025
Extended Trading
$13.10 0.00 (0.00%)
As of 04/17/2025 05:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; APEX 3D total ankle replacement systems; and total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides forefoot or hallux valgus correction systems, including phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.

InMode stock logo

InMode NASDAQ:INMD

$16.22 +0.09 (+0.56%)
Closing price 04/25/2025 04:00 PM Eastern
Extended Trading
$16.15 -0.07 (-0.43%)
As of 04/25/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

Nano-X Imaging stock logo

Nano-X Imaging NASDAQ:NNOX

$5.25 -0.07 (-1.32%)
Closing price 04/25/2025 04:00 PM Eastern
Extended Trading
$5.34 +0.09 (+1.70%)
As of 04/25/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company is headquartered in Petach Tikva, Israel.

Tandem Diabetes Care stock logo

Tandem Diabetes Care NASDAQ:TNDM

$18.06 +0.39 (+2.21%)
Closing price 04/25/2025 04:00 PM Eastern
Extended Trading
$17.83 -0.23 (-1.27%)
As of 04/25/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.